Scientific Session

100 Years of Treating Rheumatoid Arthritis: To Create Our Future We Must Understand Our Past

Speaker(s)

• 

  Michael Weinblatt, MD

  Brigham and Women's Hospital/ Harvard Medical School
  Waban, MA, United States

  Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); aclaris: Consultant (Ongoing); Amgen: Consultant (Ongoing); anaptysbio: Consultant (Ongoing), Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); canfite: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); curie bio: Consultant (Ongoing); deep cure: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); gilead: Consultant (Ongoing); ignite: Consultant (Ongoing); inmedix: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); johnson &johnson: Grant/Research Support (Ongoing); lifordi: Consultant (Ongoing); marvel bio: Consultant (Ongoing); matchpoint: Consultant (Ongoing); Merck/MSD: Consultant (Ongoing); Roche: Consultant (Ongoing); sci rhom: Consultant (Ongoing); scipher: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); set point: Consultant (Ongoing); surf therapeutics: Consultant (Ongoing); thymmune: Consultant (Ongoing); xencorp: Consultant (Ongoing); zura bio: Consultant (Ongoing)